Skip To Main Content
Cecília M Alvim on Muck Rack

Cecília M Alvim

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Cecília M

Contact Cecília M, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prognostic factors for patients treated with abiraterone

|
By Cecília M Alvim, André Mansinho, Rita S Paiva, Raquel Brás
| future-science.com
Prostate cancer is the most common malignancy in men and the second leading cause of death from cancer [1]. Most metastatic prostate cancer patients show an initial favorable response with androgen-deprivation therapy, but castration resistance inevitably develops in the majority [2].
Open in Who Shared Issue with article?
See all 1 articles